0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mifepristone Market Insights and Forecast to 2028
Published Date: May 2022
|
Report Code: QYRE-Auto-19O7878
Home | Market Reports | Health | Reproductive Health
Global Mifepristone Market Insights and Forecast to 2028

Global Mifepristone Market Insights and Forecast to 2028

Code: QYRE-Auto-19O7878
Report
May 2022
111 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Mifepristone is a progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. 
Market Analysis and Insights: Global Mifepristone Market

Due to the COVID-19 pandemic, the global Mifepristone market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, Tablets accounting for % of the Mifepristone global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients) segment is altered to an % CAGR throughout this forecast period.
China Mifepristone market size is valued at US$ million in 2021, while the US and Europe Mifepristone are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Mifepristone landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Mifepristone include Merck Serono, Pfizer, GenBioPro, Linepharma International, Monsanto/Searle, Zhejiang Xianju Pharmaceutical, Hubei Gedian Renfu Pharmaceutical, Shanghai Xinhualian Pharmaceutical and Huarun Zizhu Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Mifepristone Scope and Segment
Mifepristone market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Mifepristone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Tablets
(Soft) Capsule
Other

Segment by Application

Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients)
Pregnant,
Urged By The Check
Intrauterine Induction Of Labor After Fetal Death
Gynecologic Surgery
Other

BY COMPANY

Merck Serono
Pfizer
GenBioPro
Linepharma International
Monsanto/Searle
Zhejiang Xianju Pharmaceutical
Hubei Gedian Renfu Pharmaceutical
Shanghai Xinhualian Pharmaceutical
Huarun Zizhu Pharmaceutical
Guangzhou Longsheng Pharmaceutical
Shenzhen Zifu Pharmaceutical

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Mifepristone Product Introduction
1.2 Market by Type
1.2.1 Global Mifepristone Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tablets
1.2.3 (Soft) Capsule
1.2.4 Other
1.3 Market by Application
1.3.1 Global Mifepristone Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients)
1.3.3 Pregnant,
1.3.4 Urged By The Check
1.3.5 Intrauterine Induction Of Labor After Fetal Death
1.3.6 Gynecologic Surgery
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mifepristone Sales Estimates and Forecasts 2017-2028
2.2 Global Mifepristone Revenue Estimates and Forecasts 2017-2028
2.3 Global Mifepristone Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Mifepristone Sales by Region
2.4.1 Global Mifepristone Sales by Region (2017-2022)
2.4.2 Global Sales Mifepristone by Region (2023-2028)
2.5 Global Mifepristone Revenue by Region
2.5.1 Global Mifepristone Revenue by Region (2017-2022)
2.5.2 Global Mifepristone Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Mifepristone Sales by Manufacturers
3.1.1 Global Top Mifepristone Manufacturers by Sales (2017-2022)
3.1.2 Global Mifepristone Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mifepristone in 2021
3.2 Global Mifepristone Revenue by Manufacturers
3.2.1 Global Mifepristone Revenue by Manufacturers (2017-2022)
3.2.2 Global Mifepristone Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Mifepristone Revenue in 2021
3.3 Global Mifepristone Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Mifepristone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Mifepristone Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Mifepristone Sales by Type
4.1.1 Global Mifepristone Historical Sales by Type (2017-2022)
4.1.2 Global Mifepristone Forecasted Sales by Type (2023-2028)
4.1.3 Global Mifepristone Sales Market Share by Type (2017-2028)
4.2 Global Mifepristone Revenue by Type
4.2.1 Global Mifepristone Historical Revenue by Type (2017-2022)
4.2.2 Global Mifepristone Forecasted Revenue by Type (2023-2028)
4.2.3 Global Mifepristone Revenue Market Share by Type (2017-2028)
4.3 Global Mifepristone Price by Type
4.3.1 Global Mifepristone Price by Type (2017-2022)
4.3.2 Global Mifepristone Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Mifepristone Sales by Application
5.1.1 Global Mifepristone Historical Sales by Application (2017-2022)
5.1.2 Global Mifepristone Forecasted Sales by Application (2023-2028)
5.1.3 Global Mifepristone Sales Market Share by Application (2017-2028)
5.2 Global Mifepristone Revenue by Application
5.2.1 Global Mifepristone Historical Revenue by Application (2017-2022)
5.2.2 Global Mifepristone Forecasted Revenue by Application (2023-2028)
5.2.3 Global Mifepristone Revenue Market Share by Application (2017-2028)
5.3 Global Mifepristone Price by Application
5.3.1 Global Mifepristone Price by Application (2017-2022)
5.3.2 Global Mifepristone Price Forecast by Application (2023-2028)
6 North America
6.1 North America Mifepristone Market Size by Type
6.1.1 North America Mifepristone Sales by Type (2017-2028)
6.1.2 North America Mifepristone Revenue by Type (2017-2028)
6.2 North America Mifepristone Market Size by Application
6.2.1 North America Mifepristone Sales by Application (2017-2028)
6.2.2 North America Mifepristone Revenue by Application (2017-2028)
6.3 North America Mifepristone Market Size by Country
6.3.1 North America Mifepristone Sales by Country (2017-2028)
6.3.2 North America Mifepristone Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Mifepristone Market Size by Type
7.1.1 Europe Mifepristone Sales by Type (2017-2028)
7.1.2 Europe Mifepristone Revenue by Type (2017-2028)
7.2 Europe Mifepristone Market Size by Application
7.2.1 Europe Mifepristone Sales by Application (2017-2028)
7.2.2 Europe Mifepristone Revenue by Application (2017-2028)
7.3 Europe Mifepristone Market Size by Country
7.3.1 Europe Mifepristone Sales by Country (2017-2028)
7.3.2 Europe Mifepristone Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Mifepristone Market Size by Type
8.1.1 Asia Pacific Mifepristone Sales by Type (2017-2028)
8.1.2 Asia Pacific Mifepristone Revenue by Type (2017-2028)
8.2 Asia Pacific Mifepristone Market Size by Application
8.2.1 Asia Pacific Mifepristone Sales by Application (2017-2028)
8.2.2 Asia Pacific Mifepristone Revenue by Application (2017-2028)
8.3 Asia Pacific Mifepristone Market Size by Region
8.3.1 Asia Pacific Mifepristone Sales by Region (2017-2028)
8.3.2 Asia Pacific Mifepristone Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Mifepristone Market Size by Type
9.1.1 Latin America Mifepristone Sales by Type (2017-2028)
9.1.2 Latin America Mifepristone Revenue by Type (2017-2028)
9.2 Latin America Mifepristone Market Size by Application
9.2.1 Latin America Mifepristone Sales by Application (2017-2028)
9.2.2 Latin America Mifepristone Revenue by Application (2017-2028)
9.3 Latin America Mifepristone Market Size by Country
9.3.1 Latin America Mifepristone Sales by Country (2017-2028)
9.3.2 Latin America Mifepristone Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Mifepristone Market Size by Type
10.1.1 Middle East and Africa Mifepristone Sales by Type (2017-2028)
10.1.2 Middle East and Africa Mifepristone Revenue by Type (2017-2028)
10.2 Middle East and Africa Mifepristone Market Size by Application
10.2.1 Middle East and Africa Mifepristone Sales by Application (2017-2028)
10.2.2 Middle East and Africa Mifepristone Revenue by Application (2017-2028)
10.3 Middle East and Africa Mifepristone Market Size by Country
10.3.1 Middle East and Africa Mifepristone Sales by Country (2017-2028)
10.3.2 Middle East and Africa Mifepristone Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck Serono
11.1.1 Merck Serono Corporation Information
11.1.2 Merck Serono Overview
11.1.3 Merck Serono Mifepristone Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Serono Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Serono Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Mifepristone Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 GenBioPro
11.3.1 GenBioPro Corporation Information
11.3.2 GenBioPro Overview
11.3.3 GenBioPro Mifepristone Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GenBioPro Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GenBioPro Recent Developments
11.4 Linepharma International
11.4.1 Linepharma International Corporation Information
11.4.2 Linepharma International Overview
11.4.3 Linepharma International Mifepristone Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Linepharma International Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Linepharma International Recent Developments
11.5 Monsanto/Searle
11.5.1 Monsanto/Searle Corporation Information
11.5.2 Monsanto/Searle Overview
11.5.3 Monsanto/Searle Mifepristone Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Monsanto/Searle Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Monsanto/Searle Recent Developments
11.6 Zhejiang Xianju Pharmaceutical
11.6.1 Zhejiang Xianju Pharmaceutical Corporation Information
11.6.2 Zhejiang Xianju Pharmaceutical Overview
11.6.3 Zhejiang Xianju Pharmaceutical Mifepristone Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Zhejiang Xianju Pharmaceutical Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zhejiang Xianju Pharmaceutical Recent Developments
11.7 Hubei Gedian Renfu Pharmaceutical
11.7.1 Hubei Gedian Renfu Pharmaceutical Corporation Information
11.7.2 Hubei Gedian Renfu Pharmaceutical Overview
11.7.3 Hubei Gedian Renfu Pharmaceutical Mifepristone Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hubei Gedian Renfu Pharmaceutical Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hubei Gedian Renfu Pharmaceutical Recent Developments
11.8 Shanghai Xinhualian Pharmaceutical
11.8.1 Shanghai Xinhualian Pharmaceutical Corporation Information
11.8.2 Shanghai Xinhualian Pharmaceutical Overview
11.8.3 Shanghai Xinhualian Pharmaceutical Mifepristone Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Shanghai Xinhualian Pharmaceutical Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Shanghai Xinhualian Pharmaceutical Recent Developments
11.9 Huarun Zizhu Pharmaceutical
11.9.1 Huarun Zizhu Pharmaceutical Corporation Information
11.9.2 Huarun Zizhu Pharmaceutical Overview
11.9.3 Huarun Zizhu Pharmaceutical Mifepristone Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Huarun Zizhu Pharmaceutical Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Huarun Zizhu Pharmaceutical Recent Developments
11.10 Guangzhou Longsheng Pharmaceutical
11.10.1 Guangzhou Longsheng Pharmaceutical Corporation Information
11.10.2 Guangzhou Longsheng Pharmaceutical Overview
11.10.3 Guangzhou Longsheng Pharmaceutical Mifepristone Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Guangzhou Longsheng Pharmaceutical Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Guangzhou Longsheng Pharmaceutical Recent Developments
11.11 Shenzhen Zifu Pharmaceutical
11.11.1 Shenzhen Zifu Pharmaceutical Corporation Information
11.11.2 Shenzhen Zifu Pharmaceutical Overview
11.11.3 Shenzhen Zifu Pharmaceutical Mifepristone Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Shenzhen Zifu Pharmaceutical Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shenzhen Zifu Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Mifepristone Industry Chain Analysis
12.2 Mifepristone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mifepristone Production Mode & Process
12.4 Mifepristone Sales and Marketing
12.4.1 Mifepristone Sales Channels
12.4.2 Mifepristone Distributors
12.5 Mifepristone Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Mifepristone Industry Trends
13.2 Mifepristone Market Drivers
13.3 Mifepristone Market Challenges
13.4 Mifepristone Market Restraints
14 Key Findings in The Global Mifepristone Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Mifepristone Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Tablets
    Table 3. Major Manufacturers of (Soft) Capsule
    Table 4. Major Manufacturers of Other
    Table 5. Global Mifepristone Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Mifepristone Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Mifepristone Sales by Region (2017-2022) & (KG)
    Table 8. Global Mifepristone Sales Market Share by Region (2017-2022)
    Table 9. Global Mifepristone Sales by Region (2023-2028) & (KG)
    Table 10. Global Mifepristone Sales Market Share by Region (2023-2028)
    Table 11. Global Mifepristone Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Mifepristone Revenue Market Share by Region (2017-2022)
    Table 13. Global Mifepristone Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Mifepristone Revenue Market Share by Region (2023-2028)
    Table 15. Global Mifepristone Sales by Manufacturers (2017-2022) & (KG)
    Table 16. Global Mifepristone Sales Share by Manufacturers (2017-2022)
    Table 17. Global Mifepristone Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Mifepristone Revenue Share by Manufacturers (2017-2022)
    Table 19. Mifepristone Price by Manufacturers (2017-2022) &(US$/G)
    Table 20. Global Mifepristone Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Mifepristone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mifepristone as of 2021)
    Table 22. Mifepristone Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Mifepristone Product Offered
    Table 24. Date of Manufacturers Enter into Mifepristone Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Mifepristone Sales by Type (2017-2022) & (KG)
    Table 27. Global Mifepristone Sales by Type (2023-2028) & (KG)
    Table 28. Global Mifepristone Sales Share by Type (2017-2022)
    Table 29. Global Mifepristone Sales Share by Type (2023-2028)
    Table 30. Global Mifepristone Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Mifepristone Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Mifepristone Revenue Share by Type (2017-2022)
    Table 33. Global Mifepristone Revenue Share by Type (2023-2028)
    Table 34. Mifepristone Price by Type (2017-2022) & (US$/G)
    Table 35. Global Mifepristone Price Forecast by Type (2023-2028) & (US$/G)
    Table 36. Global Mifepristone Sales by Application (2017-2022) & (KG)
    Table 37. Global Mifepristone Sales by Application (2023-2028) & (KG)
    Table 38. Global Mifepristone Sales Share by Application (2017-2022)
    Table 39. Global Mifepristone Sales Share by Application (2023-2028)
    Table 40. Global Mifepristone Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Mifepristone Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Mifepristone Revenue Share by Application (2017-2022)
    Table 43. Global Mifepristone Revenue Share by Application (2023-2028)
    Table 44. Mifepristone Price by Application (2017-2022) & (US$/G)
    Table 45. Global Mifepristone Price Forecast by Application (2023-2028) & (US$/G)
    Table 46. North America Mifepristone Sales by Type (2017-2022) & (KG)
    Table 47. North America Mifepristone Sales by Type (2023-2028) & (KG)
    Table 48. North America Mifepristone Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Mifepristone Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Mifepristone Sales by Application (2017-2022) & (KG)
    Table 51. North America Mifepristone Sales by Application (2023-2028) & (KG)
    Table 52. North America Mifepristone Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Mifepristone Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Mifepristone Sales by Country (2017-2022) & (KG)
    Table 55. North America Mifepristone Sales by Country (2023-2028) & (KG)
    Table 56. North America Mifepristone Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Mifepristone Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Mifepristone Sales by Type (2017-2022) & (KG)
    Table 59. Europe Mifepristone Sales by Type (2023-2028) & (KG)
    Table 60. Europe Mifepristone Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Mifepristone Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Mifepristone Sales by Application (2017-2022) & (KG)
    Table 63. Europe Mifepristone Sales by Application (2023-2028) & (KG)
    Table 64. Europe Mifepristone Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Mifepristone Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Mifepristone Sales by Country (2017-2022) & (KG)
    Table 67. Europe Mifepristone Sales by Country (2023-2028) & (KG)
    Table 68. Europe Mifepristone Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Mifepristone Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Mifepristone Sales by Type (2017-2022) & (KG)
    Table 71. Asia Pacific Mifepristone Sales by Type (2023-2028) & (KG)
    Table 72. Asia Pacific Mifepristone Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Mifepristone Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Mifepristone Sales by Application (2017-2022) & (KG)
    Table 75. Asia Pacific Mifepristone Sales by Application (2023-2028) & (KG)
    Table 76. Asia Pacific Mifepristone Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Mifepristone Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Mifepristone Sales by Region (2017-2022) & (KG)
    Table 79. Asia Pacific Mifepristone Sales by Region (2023-2028) & (KG)
    Table 80. Asia Pacific Mifepristone Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Mifepristone Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Mifepristone Sales by Type (2017-2022) & (KG)
    Table 83. Latin America Mifepristone Sales by Type (2023-2028) & (KG)
    Table 84. Latin America Mifepristone Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Mifepristone Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Mifepristone Sales by Application (2017-2022) & (KG)
    Table 87. Latin America Mifepristone Sales by Application (2023-2028) & (KG)
    Table 88. Latin America Mifepristone Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Mifepristone Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Mifepristone Sales by Country (2017-2022) & (KG)
    Table 91. Latin America Mifepristone Sales by Country (2023-2028) & (KG)
    Table 92. Latin America Mifepristone Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Mifepristone Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Mifepristone Sales by Type (2017-2022) & (KG)
    Table 95. Middle East and Africa Mifepristone Sales by Type (2023-2028) & (KG)
    Table 96. Middle East and Africa Mifepristone Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Mifepristone Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Mifepristone Sales by Application (2017-2022) & (KG)
    Table 99. Middle East and Africa Mifepristone Sales by Application (2023-2028) & (KG)
    Table 100. Middle East and Africa Mifepristone Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Mifepristone Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Mifepristone Sales by Country (2017-2022) & (KG)
    Table 103. Middle East and Africa Mifepristone Sales by Country (2023-2028) & (KG)
    Table 104. Middle East and Africa Mifepristone Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Mifepristone Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Merck Serono Corporation Information
    Table 107. Merck Serono Description and Major Businesses
    Table 108. Merck Serono Mifepristone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 109. Merck Serono Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Merck Serono Recent Developments
    Table 111. Pfizer Corporation Information
    Table 112. Pfizer Description and Major Businesses
    Table 113. Pfizer Mifepristone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 114. Pfizer Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Pfizer Recent Developments
    Table 116. GenBioPro Corporation Information
    Table 117. GenBioPro Description and Major Businesses
    Table 118. GenBioPro Mifepristone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 119. GenBioPro Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. GenBioPro Recent Developments
    Table 121. Linepharma International Corporation Information
    Table 122. Linepharma International Description and Major Businesses
    Table 123. Linepharma International Mifepristone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 124. Linepharma International Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Linepharma International Recent Developments
    Table 126. Monsanto/Searle Corporation Information
    Table 127. Monsanto/Searle Description and Major Businesses
    Table 128. Monsanto/Searle Mifepristone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 129. Monsanto/Searle Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Monsanto/Searle Recent Developments
    Table 131. Zhejiang Xianju Pharmaceutical Corporation Information
    Table 132. Zhejiang Xianju Pharmaceutical Description and Major Businesses
    Table 133. Zhejiang Xianju Pharmaceutical Mifepristone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 134. Zhejiang Xianju Pharmaceutical Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Zhejiang Xianju Pharmaceutical Recent Developments
    Table 136. Hubei Gedian Renfu Pharmaceutical Corporation Information
    Table 137. Hubei Gedian Renfu Pharmaceutical Description and Major Businesses
    Table 138. Hubei Gedian Renfu Pharmaceutical Mifepristone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 139. Hubei Gedian Renfu Pharmaceutical Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Hubei Gedian Renfu Pharmaceutical Recent Developments
    Table 141. Shanghai Xinhualian Pharmaceutical Corporation Information
    Table 142. Shanghai Xinhualian Pharmaceutical Description and Major Businesses
    Table 143. Shanghai Xinhualian Pharmaceutical Mifepristone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 144. Shanghai Xinhualian Pharmaceutical Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Shanghai Xinhualian Pharmaceutical Recent Developments
    Table 146. Huarun Zizhu Pharmaceutical Corporation Information
    Table 147. Huarun Zizhu Pharmaceutical Description and Major Businesses
    Table 148. Huarun Zizhu Pharmaceutical Mifepristone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 149. Huarun Zizhu Pharmaceutical Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Huarun Zizhu Pharmaceutical Recent Developments
    Table 151. Guangzhou Longsheng Pharmaceutical Corporation Information
    Table 152. Guangzhou Longsheng Pharmaceutical Description and Major Businesses
    Table 153. Guangzhou Longsheng Pharmaceutical Mifepristone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 154. Guangzhou Longsheng Pharmaceutical Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Guangzhou Longsheng Pharmaceutical Recent Developments
    Table 156. Shenzhen Zifu Pharmaceutical Corporation Information
    Table 157. Shenzhen Zifu Pharmaceutical Description and Major Businesses
    Table 158. Shenzhen Zifu Pharmaceutical Mifepristone Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2017-2022)
    Table 159. Shenzhen Zifu Pharmaceutical Mifepristone Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Shenzhen Zifu Pharmaceutical Recent Developments
    Table 161. Key Raw Materials Lists
    Table 162. Raw Materials Key Suppliers Lists
    Table 163. Mifepristone Distributors List
    Table 164. Mifepristone Customers List
    Table 165. Mifepristone Market Trends
    Table 166. Mifepristone Market Drivers
    Table 167. Mifepristone Market Challenges
    Table 168. Mifepristone Market Restraints
    Table 169. Research Programs/Design for This Report
    Table 170. Key Data Information from Secondary Sources
    Table 171. Key Data Information from Primary Sources
List of Figures
    Figure 1. Mifepristone Product Picture
    Figure 3. Global Mifepristone Market Share by Type in 2021 & 2028
    Figure 3. Tablets Product Picture
    Figure 4. (Soft) Capsule Product Picture
    Figure 5. Other Product Picture
    Figure 6. Global Mifepristone Market Share by Application in 2021 & 2028
    Figure 7. Anti-Early And Mid-Term Pregnancy Drugs (Abortifacients)
    Figure 8. Pregnant,
    Figure 9. Urged By The Check
    Figure 10. Intrauterine Induction Of Labor After Fetal Death
    Figure 11. Gynecologic Surgery
    Figure 12. Other
    Figure 13. Mifepristone Report Years Considered
    Figure 14. Global Mifepristone Sales 2017-2028 (KG)
    Figure 15. Global Mifepristone Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Mifepristone Revenue 2017-2028 (US$ Million)
    Figure 17. Global Mifepristone Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Mifepristone Sales Market Share by Region (2017-2022)
    Figure 19. Global Mifepristone Sales Market Share by Region (2023-2028)
    Figure 20. North America Mifepristone Sales YoY (2017-2028) & (KG)
    Figure 21. North America Mifepristone Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Mifepristone Sales YoY (2017-2028) & (KG)
    Figure 23. Europe Mifepristone Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Mifepristone Sales YoY (2017-2028) & (KG)
    Figure 25. Asia-Pacific Mifepristone Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Mifepristone Sales YoY (2017-2028) & (KG)
    Figure 27. Latin America Mifepristone Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Mifepristone Sales YoY (2017-2028) & (KG)
    Figure 29. Middle East & Africa Mifepristone Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Mifepristone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Mifepristone in the World: Market Share by Mifepristone Revenue in 2021
    Figure 32. Global Mifepristone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Mifepristone Sales Market Share by Type (2017-2028)
    Figure 34. Global Mifepristone Revenue Market Share by Type (2017-2028)
    Figure 35. Global Mifepristone Sales Market Share by Application (2017-2028)
    Figure 36. Global Mifepristone Revenue Market Share by Application (2017-2028)
    Figure 37. North America Mifepristone Sales Market Share by Type (2017-2028)
    Figure 38. North America Mifepristone Revenue Market Share by Type (2017-2028)
    Figure 39. North America Mifepristone Sales Market Share by Application (2017-2028)
    Figure 40. North America Mifepristone Revenue Market Share by Application (2017-2028)
    Figure 41. North America Mifepristone Sales Share by Country (2017-2028)
    Figure 42. North America Mifepristone Revenue Share by Country (2017-2028)
    Figure 43. U.S. Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Mifepristone Sales Market Share by Type (2017-2028)
    Figure 46. Europe Mifepristone Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Mifepristone Sales Market Share by Application (2017-2028)
    Figure 48. Europe Mifepristone Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Mifepristone Sales Share by Country (2017-2028)
    Figure 50. Europe Mifepristone Revenue Share by Country (2017-2028)
    Figure 51. Germany Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 52. France Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Mifepristone Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Mifepristone Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Mifepristone Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Mifepristone Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Mifepristone Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Mifepristone Revenue Share by Region (2017-2028)
    Figure 62. China Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 65. India Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Mifepristone Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Mifepristone Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Mifepristone Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Mifepristone Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Mifepristone Sales Share by Country (2017-2028)
    Figure 77. Latin America Mifepristone Revenue Share by Country (2017-2028)
    Figure 78. Mexico Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Mifepristone Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Mifepristone Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Mifepristone Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Mifepristone Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Mifepristone Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Mifepristone Revenue Share by Country (2017-2028)
    Figure 87. Turkey Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 89. UAE Mifepristone Revenue (2017-2028) & (US$ Million)
    Figure 90. Mifepristone Value Chain
    Figure 91. Mifepristone Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global and United States Sexually Transmitted Disease Therapeutics Market Report Forecast 2022 2028
Global and United States Sexually Transmitted Disease Therapeutics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Othe-412
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States In Vitro Diagnostics Systems Market Report Forecast 2022 2028
Global and United States In Vitro Diagnostics Systems Market Report & Forecast 2022-2028

In vitro diagnostics are diagnostic tests that that can detect diseases conditions or infections.Market Analysis and Insights Global and United States In Vitro Diagnostics Systems MarketThis report focuses on global and United States In Vitro Diagnostics Systems market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global In Vitro Diagnostics Systems market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-12G10564
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Uterine Cancer Therapies and Diagnostic Market Report Forecast 2022 2028
Global and United States Uterine Cancer Therapies and Diagnostic Market Report & Forecast 2022-2028

Uterine cancer is a common form of cancer of the female reproductive system that initiates in the lining of the uterus.Market Analysis and Insights Global and United States Uterine Cancer Therapies and Diagnostic MarketThis report focuses on global and United States Uterine Cancer Therapies and Diagnostic market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Uterine Cancer Therapies and Diagnostic market size is estimated to be worth US 21650 million in 2022 and is forecast to a readjusted size of US 28120 million by 2028 with a CAGR of 4.5 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-1I10683
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Prenatal Testing and Newborn Screening Market Report Forecast 2022 2028
Global and United States Prenatal Testing and Newborn Screening Market Report & Forecast 2022-2028

Newborn screening is performed after the baby is born.Market Analysis and Insights Global and United States Prenatal Testing and Newborn Screening MarketThis report focuses on global and United States Prenatal Testing and Newborn Screening market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Prenatal Testing and Newborn Screening market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24T10249
Tue Jun 07 00:00:00 UTC 2022

Add to Cart